CRL

Elite Trades From Anywhere Elite Trades All Summer

$100 Off Your First Year Get Elite For Just $199.50

Peers: ICLR IQV MEDP LH DGX TMO A DHR WAT BIO

| Held by: VTI VOO RSP VB IVV VBR SPY XLV IBB DFAT

Index	S&P 500
Market Cap	10.49B
Enterprise Value	13.41B
Income	-184.65M
Sales	4.03B
Book/sh	61.05
Cash/sh	4.02
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	19700
IPO	Jun 23, 2000

P/E	-
Forward P/E	17.66
PEG	1.89
P/S	2.60
P/B	3.57
P/C	54.13
P/FCF	26.80
EV/EBITDA	15.36
EV/Sales	3.33
Quick Ratio	1.03
Current Ratio	1.36
Debt/Eq	1.04
LT Debt/Eq	1.04
Option/Short	Yes / Yes

EPS (ttm)	-3.76
EPS next Y	12.33
EPS next Q	2.73
EPS this Y	7.91%
EPS next Y	11.12%
EPS next 5Y	9.34%
EPS past 3/5Y	- -
Sales past 3/5Y	0.33% 6.55%
EPS Y/Y TTM	-492.25%
Sales Y/Y TTM	0.11%
EPS Q/Q	-160.54%
Sales Q/Q	1.18%
Earnings	May 07 BMO
EPS/Sales Surpr.	5.99% 1.88%

Insider Own	1.28%
Insider Trans	-0.06%
Inst Own	121.54%
Inst Trans	11.60%
ROA	-2.41%
ROE	-6.02%
ROIC	-3.08%
Gross Margin	31.25%
Oper. Margin	12.98%
Profit Margin	-4.59%
SMA20	14.62%
SMA50	22.62%
SMA200	21.44%
Trades

Shs Outstand	48.17M
Shs Float	47.55M
Short Float	7.60%
Short Ratio	4.11
Short Interest	3.61M
52W High	228.88 -4.87%
52W Low	144.26 50.93%
Volatility	4.64% 4.57%
ATR (14)	8.17
RSI (14)	74.43
Beta	1.37
Rel Volume	0.72
Avg Volume	878.95K
Volume	105,940

Perf Week	19.92%
Perf Month	20.06%
Perf Quarter	36.80%
Perf Half Y	7.17%
Perf YTD	9.15%
Perf Year	45.14%
Perf 3Y	4.09%
Perf 5Y	-41.42%
Perf 10Y	170.13%
Recom	1.80
Target Price	221.07
Prev Close	215.75
Price	217.73
Change	0.92%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-17-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$220
May-29-26	Upgrade	CLSA	Hold → Outperform	$219
Apr-14-26	Initiated	RBC Capital Mkts	Outperform	$215
Dec-15-25	Upgrade	BofA Securities	Neutral → Buy	$225
Nov-17-25	Upgrade	Argus	Hold → Buy
Nov-06-25	Upgrade	Robert W. Baird	Neutral → Outperform	$199
Oct-06-25	Upgrade	William Blair	Mkt Perform → Outperform
Oct-02-25	Upgrade	Barclays	Equal Weight → Overweight	$195
Sep-09-25	Upgrade	Jefferies	Hold → Buy	$195
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$200
May-23-25	Upgrade	Redburn Atlantic	Neutral → Buy	$182
May-14-25	Upgrade	TD Cowen	Hold → Buy	$179
May-08-25	Upgrade	Evercore ISI	In-line → Outperform	$170
Mar-21-25	Downgrade	Goldman	Buy → Neutral	$190 → $170
Mar-04-25	Upgrade	Citigroup	Sell → Neutral	$155 → $175
Mar-03-25	Upgrade	Redburn Atlantic	Sell → Neutral	$188
Jan-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Jan-17-25	Downgrade	UBS	Buy → Neutral	$250 → $185
Nov-18-24	Downgrade	CLSA	Hold → Underperform	$164
Nov-07-24	Upgrade	CLSA	Underperform → Hold	$205

Show Previous Ratings

Jun-24-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +8.31% +5.25%
08:05AM	S&P 500 opens in green as big tech stabilizes ahead of Micron earnings (Proactive)
02:18AM	FTSE 100 Live: Stocks creep higher as Segro surges, but gold tests 7-month lows (Proactive)
Jun-19-26 06:07AM	Charles River collaborates with Lilly TuneLab platform (Hospital Management)
Jun-18-26 08:00AM	Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise (Business Wire)
09:47AM	Loading…
Jun-17-26 09:47AM	Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls (The Fly)
09:13AM	Morgan Stanley favors Charles River Over IQVIA in CRO sector reset (Investing.com)
May-29-26 09:40AM	Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls (The Fly)
May-28-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch) +10.24%
May-27-26 04:30PM	Charles River Laboratories International Inc. stock outperforms competitors on strong trading day (MarketWatch)
May-15-26 04:30PM	Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors (MarketWatch) -5.20%
May-13-26 08:00AM	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions (Business Wire)
May-11-26 08:00AM	Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow (Business Wire) -5.16%
May-07-26 08:27PM	Charles River Laboratories International, Inc. Q1 2026 Earnings Call Summary (Moby)
07:11AM	Charles River: Q1 Earnings Snapshot (Associated Press)
07:00AM	Loading…
07:00AM	Charles River Laboratories Announces First-Quarter 2026 Results (Business Wire)
Apr-30-26 08:00AM	Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities (Business Wire)
Apr-21-26 08:00AM	Charles River Highlights Effectiveness of VCGs in Toxicology (Business Wire)
Apr-16-26 08:00AM	Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call (Business Wire)
Apr-14-26 09:53AM	Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls (The Fly)
Apr-09-26 04:30PM	Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association (Business Wire)
Apr-06-26 08:55AM	NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX (PR Newswire)
Mar-10-26 10:30AM	Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand (Insider Monkey) -5.44%
Mar-09-26 11:33PM	A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack (StockStory)
Mar-05-26 10:34AM	Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds (Insider Monkey)
Mar-02-26 08:00AM	Charles River Laboratories to Present at TD Cowen and Barclays Conferences (Business Wire)
Feb-26-26 06:42AM	IQVIA to acquire Charles River drug discovery assets (Pharmaceutical Technology)
Feb-25-26 09:06AM	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans (Benzinga)
07:00AM	Charles River Laboratories Provides Update on Planned Divestitures (Business Wire)
Feb-24-26 02:38PM	Baird Maintains Outperform Rating on Charles River Laboratories International, Inc. (CRL) (Insider Monkey)
09:40AM	Loading…
09:40AM	Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term (Zacks)
Feb-23-26 09:15AM	Investing in Charles River (CRL)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Feb-20-26 08:03AM	What Are Wall Street Analysts' Target Price for Charles River Laboratories Stock? (Barchart)
Feb-19-26 10:20PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
12:33AM	CRL Q4 Deep Dive: Flat Sales and Margin Pressures as Biotech Demand Recovers (StockStory)
Feb-18-26 04:06PM	Charles River Laboratories International Inc (CRL) Q4 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
12:49PM	Charles River Laboratories International Q4 Earnings Call Highlights (MarketBeat)
12:33PM	Charles River Laboratories International, Inc. Q4 2025 Earnings Call Summary (Moby)
09:30AM	Here's What Key Metrics Tell Us About Charles River (CRL) Q4 Earnings (Zacks)
08:55AM	CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise (Zacks)
08:10AM	Charles River Laboratories (CRL) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:33AM	Charles River Laboratories (NYSE:CRL) Beats Q4 CY2025 Sales Expectations (StockStory)
07:16AM	Charles River: Q4 Earnings Snapshot (Associated Press Finance)
07:01AM	Charles River Laboratories Announces Executive Appointments (Business Wire)
07:00AM	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance (Business Wire)
Feb-16-26 10:05PM	Charles River Laboratories (CRL) Q4 Earnings: What To Expect (StockStory)
09:15AM	What Analyst Projections for Key Metrics Reveal About Charles River (CRL) Q4 Earnings (Zacks)
Feb-15-26 08:58AM	Analysts Are Bullish On Charles River Laboratories (CRL) Prospects (Insider Monkey)
Feb-13-26 09:39AM	Here's How Charles River Stock Is Placed Ahead of Q4 Earnings (Zacks)
07:01AM	Mariner selects State Streets Charles River wealth platform (Private Banker International)
Feb-12-26 02:27PM	Mariner Has Big Growth Plans. State Streets Charles River Is Supplying the Tech Platform. (Barrons.com)
Feb-11-26 08:21PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -8.42%
10:00AM	Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-10-26 11:34PM	1 S&P 500 Stock with Competitive Advantages and 2 We Ignore (StockStory)
Feb-08-26 11:01PM	Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Feb-02-26 07:15AM	Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates (Zacks)
Jan-27-26 08:10AM	HCA Healthcare (HCA) Beats Q4 Earnings Estimates (Zacks)
Jan-21-26 04:30PM	Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call (Business Wire)
08:00AM	Charles River Enters Manufacturing Collaboration with Gazi University (Business Wire)
Jan-20-26 11:04AM	Organon Secures FDA Approval Extending NEXPLANON Use to Five Years (Zacks)
11:00AM	Here's Why You Should Retain CLOV Stock in Your Portfolio for Now (Zacks)
Jan-19-26 05:59AM	What to Expect From Charles River Laboratories Next Quarterly Earnings Report (Barchart)
Jan-15-26 12:00PM	Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy (Zacks)
09:42AM	Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? (Zacks)
Jan-12-26 04:30PM	Charles River Laboratories Provides Business Updates (Business Wire)
08:57AM	RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models (Zacks)
Jan-09-26 07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 08:00AM	Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan (Business Wire)
Jan-06-26 12:00PM	What Makes Charles River (CRL) a New Buy Stock (Zacks)
09:15AM	Charles River Laboratories International, Inc. (CRL) Hit a 52 Week High, Can the Run Continue? (Zacks)
Dec-22-25 03:00PM	Why Charles River Laboratories (CRL) Stock Is Trading Up Today (StockStory)
Dec-18-25 08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)
Dec-16-25 05:24AM	Is Charles River Laboratories Stock Underperforming the Dow? (Barchart)
Dec-15-25 04:36PM	Stocks Fall Ahead of US November Payroll Report (Barchart)
Dec-11-25 08:00AM	Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort (Business Wire)
Dec-03-25 04:55PM	Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know (StockStory) +5.67%
Dec-01-25 03:42PM	HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
Nov-24-25 07:56AM	What Makes Charles River Laboratories (CRL) an Investment Bet? (Insider Monkey)
Nov-21-25 03:24AM	Charles River Laboratories Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-20-25 11:54AM	MA life sciences company Charles River Laboratories to lay off dozens of workers in 2026 (Worcester Telegram & Gazette)
Nov-17-25 09:15AM	Charles River (CRL) International Revenue Performance Explored (Zacks)
08:00AM	Charles River Laboratories to Present at Jefferies Global Healthcare Conference (Business Wire)
Nov-16-25 10:37PM	Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest (StockStory)
Nov-12-25 12:32AM	5 Must-Read Analyst Questions From Charles River Laboratories's Q3 Earnings Call (StockStory)
Nov-06-25 03:58PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
12:31AM	CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook (StockStory)
Nov-05-25 08:15PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -5.71%
04:03PM	Charles River Laboratories International Inc (CRL) Q3 2025 Earnings Call Highlights: Strategic ... (GuruFocus.com)
12:26PM	Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today (StockStory)
09:30AM	Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:22AM	CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls (Zacks)
08:10AM	Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
07:51AM	Charles River Laboratories's (NYSE:CRL) Q3: Beats On Revenue (StockStory)
07:22AM	Charles River: Q3 Earnings Snapshot (Associated Press Finance)
07:01AM	Charles River Laboratories Provides Update on Strategic Review (Business Wire)
07:00AM	Charles River Laboratories Announces Third-Quarter 2025 Results (Business Wire)
Nov-03-25 10:12PM	What To Expect From Charles River Laboratories's (CRL) Q3 Earnings (StockStory)
Oct-30-25 10:00AM	Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 10:00AM	Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-27-25 07:17PM	HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

CEO & DirectorMs. Birgit Girshick

Corporate Senior VP & Chief Accounting OfficerMr. Michael Gunnar Knell

Corporate Executive Vice President of Corporate Development & StrategyMr. Joseph W. LaPlume J.D.

Corporate Executive VP & Chief People OfficerMs. Victoria L. Creamer

Corporate Executive VP & CFOMr. Glenn G. Coleman CPA

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LaPlume Joseph W	EVP, Corp Strategy & Develop	Mar 03 '26	Buy	174.54	25	4,364	27,448	Mar 04 04:39 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 22 '25	Sale	163.72	400	65,488	23,716	Jan 20 08:49 AM
Joseph LaPlume	Officer	Aug 22 '25	Proposed Sale	152.50	400	61,000		Aug 22 01:37 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 18 '25	Sale	157.60	800	126,080	24,116	Aug 20 04:45 PM
WALLMAN RICHARD F	Former Director	Aug 18 '25	Proposed Sale	152.00	22,500	3,420,000		Aug 18 05:16 PM
Joseph LaPlume	Officer	Aug 18 '25	Proposed Sale	157.00	800	125,600		Aug 18 01:27 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 07 '25	Sale	150.04	400	60,016	24,916	Aug 08 04:18 PM
Joseph LaPlume	Officer	Aug 07 '25	Proposed Sale	150.00	400	60,000		Aug 07 02:57 PM
WALLMAN RICHARD F	Former Director	Jul 21 '25	Proposed Sale	150.00	8,500	1,275,000		Jul 21 04:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

Charles River Laboratories International Inc

Upgrade your Finviz experience